| scholarly article | Q13442814 |
| P2093 | author name string | Ning Li | |
| Tao Chen | |||
| Zhong-Hua Chen | |||
| Ke-Zhi Zhang | |||
| Xue-Qin Lv | |||
| Na Long | |||
| Fei-Peng Zhang | |||
| Li-Shan Lin | |||
| Pei-Zhen Ye | |||
| Su-Xing Zhang | |||
| P2860 | cites work | High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. V. Validation of a direct injection/on-line guard cartridge extraction--tandem mass spectrometry method for CYP1A2 inhibition assessment | Q32079778 |
| An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point | Q33347238 | ||
| Drug-drug interactions of new active substances: mibefradil example | Q33763217 | ||
| Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo | Q35130543 | ||
| Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios | Q35860313 | ||
| Leflunomide and warfarin interaction: case report and review of the literature | Q36484975 | ||
| Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Isolation of an NN-bridged benzyne-protoporphyrin IX adduct. | Q42028850 | ||
| A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry | Q43513018 | ||
| Cocktail-substrate approach-based high-throughput assay for evaluation of direct and time-dependent inhibition of multiple cytochrome P450 isoforms | Q44188502 | ||
| Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes | Q44524934 | ||
| Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine | Q44550572 | ||
| Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator? | Q46125307 | ||
| Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes | Q46686355 | ||
| In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A. | Q46792862 | ||
| The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America | Q48024763 | ||
| In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies | Q58734935 | ||
| Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences | Q70591704 | ||
| Cisapride and fatal arrhythmia | Q71133416 | ||
| Tacrolimus/itraconazole interactions: a case report of ABO-incompatible living-related renal transplantation | Q73011042 | ||
| Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations | Q73393390 | ||
| An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS | Q83096106 | ||
| Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards | Q83877000 | ||
| Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse | Q87543493 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 708-718 | |
| P577 | publication date | 2016-04-11 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s | |
| P478 | volume | 37 |
| Q93194413 | Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping |
| Q88779209 | Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone |
| Q90645483 | Hepatic Enzymes Relevant to the Disposition of (-)-∆9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, 11-OH-THC |
Search more.